An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance

[1]  E. Furth,et al.  EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.

[2]  R. Flavell,et al.  ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates , 2018, The Journal of experimental medicine.

[3]  Toshio Uraoka,et al.  A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis. , 2016, Cell stem cell.

[4]  A. S. Nateri,et al.  Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer , 2016, Stem Cell Reviews and Reports.

[5]  B. Spencer‐Dene,et al.  Fbxw7-associated drug resistance is reversed by induction of terminal differentiation in murine intestinal organoid culture , 2016, Molecular Therapy: Methods & Clinical Development.

[6]  L. Bird,et al.  Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection , 2015, The Journal of experimental medicine.

[7]  I. Zlobec,et al.  Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer , 2015, British Journal of Cancer.

[8]  E. Martinelli,et al.  Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer , 2015, Oncotarget.

[9]  Hayley E. Francies,et al.  Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.

[10]  I. Tomlinson,et al.  FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15 , 2015, Oncotarget.

[11]  Xiaofei Lu,et al.  FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells , 2015, Oncotarget.

[12]  Xinjia Zhou,et al.  FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein , 2015, Tumor Biology.

[13]  長﨑 高也.  Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis : anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction , 2014 .

[14]  M. Biffoni,et al.  CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. , 2014, Cell stem cell.

[15]  Mikinori Sato,et al.  Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction , 2013, British Journal of Cancer.

[16]  M. Nieto.  Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells , 2013, Science.

[17]  I. Tomlinson,et al.  Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines , 2013, Gut.

[18]  J. Mao,et al.  Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells. , 2013, Biochemical and biophysical research communications.

[19]  Jun‐hang Luo,et al.  Protein Expression of ZEB2 in Renal Cell Carcinoma and Its Prognostic Significance in Patient Survival , 2013, PloS one.

[20]  M. Prasad,et al.  Interactions between Twist and other core epithelial–mesenchymal transition factors are controlled by GSK3-mediated phosphorylation , 2013, Nature Communications.

[21]  L. Ellis,et al.  Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. , 2013, Cancer cell.

[22]  H. Clevers,et al.  Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties , 2013, Cell.

[23]  Hao Wang,et al.  ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma , 2012, PloS one.

[24]  Semi Kim,et al.  ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells. , 2012, Carcinogenesis.

[25]  J. Huo,et al.  ZEB2 Promotes the Metastasis of Gastric Cancer and Modulates Epithelial Mesenchymal Transition of Gastric Cancer Cells , 2012, Digestive Diseases and Sciences.

[26]  Zhiwei Wang,et al.  Emerging roles of the FBW7 tumour suppressor in stem cell differentiation , 2012, EMBO reports.

[27]  M. Koch,et al.  Overexpression of ZEB2 at the Invasion Front of Colorectal Cancer Is an Independent Prognostic Marker and Regulates Tumor Invasion In Vitro , 2011, Clinical Cancer Research.

[28]  C. LaBonne,et al.  The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1 , 2011, The Journal of cell biology.

[29]  G. Berx,et al.  The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization. , 2011, Blood.

[30]  Erika Pastrana,et al.  Eyes wide open: a critical review of sphere-formation as an assay for stem cells. , 2011, Cell stem cell.

[31]  Hans Clevers,et al.  The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.

[32]  Tae Jin Lee,et al.  p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2 , 2011, The Journal of experimental medicine.

[33]  B. Spencer‐Dene,et al.  FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation , 2011, The Journal of experimental medicine.

[34]  I. Tomlinson,et al.  F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor. , 2010, Gastroenterology.

[35]  Jialiang Liang,et al.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. , 2010, Cell stem cell.

[36]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[37]  B. Nordlinger,et al.  Colorectal cancer , 2010, The Lancet.

[38]  G. Browne,et al.  ZEB proteins link cell motility with cell cycle control and cell survival in cancer , 2010, Cell cycle.

[39]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[40]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[41]  Klaus-Armin Nave,et al.  Sip1 regulates sequential fate decisions by feedback signaling from postmitotic neurons to progenitors , 2009, Nature Neuroscience.

[42]  Michael C. Ostrowski,et al.  Genomic alterations in tumor stroma. , 2009, Cancer research.

[43]  Marina Kriajevska,et al.  SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer , 2009, Proceedings of the National Academy of Sciences.

[44]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[45]  G. Berx,et al.  The role of the ZEB family of transcription factors in development and disease , 2009, Cellular and Molecular Life Sciences.

[46]  F. Portillo,et al.  Transcriptional regulation of cell polarity in EMT and cancer , 2008, Oncogene.

[47]  R. Maestro,et al.  Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. , 2008, Cancer cell.

[48]  M. Korpal,et al.  The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.

[49]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[50]  R. DePinho,et al.  LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis , 2008, Nature Genetics.

[51]  B. Clurman,et al.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation , 2008, Nature Reviews Cancer.

[52]  V. Tarabykin,et al.  Smad-interacting protein-1 (Zfhx1b) acts upstream of Wnt signaling in the mouse hippocampus and controls its formation , 2007, Proceedings of the National Academy of Sciences.

[53]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[54]  H. Kiyono,et al.  Intestinal Lamina Propria Retaining CD4+CD25+ Regulatory T Cells Is A Suppressive Site of Intestinal Inflammation1 , 2007, The Journal of Immunology.

[55]  Xin-Yuan Fu,et al.  Smad4 signalling in T cells is required for suppression of gastrointestinal cancer , 2006, Nature.

[56]  T. Ratliff.  TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .

[57]  P. Johnston,et al.  Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan , 2004, Clinical Cancer Research.

[58]  A. Behrens,et al.  The Ubiquitin Ligase SCFFbw7 Antagonizes Apoptotic JNK Signaling , 2004, Science.

[59]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[60]  S. Nandi,et al.  Beware of contaminating mouse cells in human xenografts from nude mice. , 2000, Anticancer research.

[61]  L. Nelles,et al.  SIP1, a Novel Zinc Finger/Homeodomain Repressor, Interacts with Smad Proteins and Binds to 5′-CACCT Sequences in Candidate Target Genes* , 1999, The Journal of Biological Chemistry.

[62]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.